Supreme Reports Granting of Options

OCTOBER 14, 2015

 

October 14, 2014 – Supreme Pharmaceuticals Inc.(SPRWF – OTC) (“SL” – CSE) announced today that it has issued 4,100,000 stock options to directors, officers, employees and consultants.Each option entitles the holder to acquire one common share of the Company for a period of five years (3,900,000 options) or two years (200,000 options), at a price of $0.41 per share.These options were issued in accordance with the Company’s incentive stock option plan.

Contact Information

Investor Relations
430 – 580 Hornby Street, Vancouver BC
V6C 3B6

Phone: (604) 674-2191
Email: info@supreme.ca
Website: www.supreme.ca